Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001493152-26-003634

Options or other derivatives

  • CHAIRMAN AND CEO acquired 4,426 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Trieu Vuong · CHAIRMAN AND CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-22 Grant or award : show line 1 in the form Series A Convertible Preferred Stock +4,426 8,491 D
Loading xslF345X05/ownership.xml…